The total return over the past 12 months is -97.86% vs. +16.94% for the S&P 500. So far it's up -95.54% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (97.86%) | (71.83%) | (71.40%) | N/A | N/A | N/A |
| Total Return CAGR | (97.86%) | (71.83%) | (71.40%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Niki BioSolutions, Inc. (NIKI)
| Year | Start price | End price | NIKI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $106.00 | $4.73 | (95.54%) | +14.51% | (110.05%) |
| 2025 | $280.00 | $106.00 | (62.14%) | +17.72% | (79.86%) |
| 2024 | $244.90 | $280.00 | +14.33% | +24.89% | (10.56%) |
| 2023 | $550.00 | $244.90 | (55.47%) | +26.19% | (81.66%) |
| 2022 | $1,500.00 | $550.00 | (63.33%) | (18.17%) | (45.16%) |
| 2021 | $2,470.00 | $1,500.00 | (39.27%) | +28.74% | (68.01%) |
| 2020 | $15,850.00 | $2,470.00 | (84.42%) | +18.37% | (102.79%) |
| 2019 | $15,180.00 | $15,850.00 | +4.41% | +31.22% | (26.81%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
